Graft Rejection
📧 Sign up to get email alerts when something new happens for Graft Rejection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: Stress Cardiac MRI for Evaluation of Nonspecific Allograft Dysfunction [Phase 4]
Phase 4 study evaluating Stress Cardiac MRI for nonspecific allograft dysfunction in heart transplant recipients has completed with results …
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: The Effect of Human Leukocyte Antigen Macthing on Guiding Tacrolimus Regimen After Liver Transplantation [NA]
Clinical trial assessing whether HLA matching can guide tacrolimus dosing after liver transplantation. The study also considers outcomes rel…
-
CLINICAL_TRIALS trial_result · 2016-11-29Clinical Trial Update: Study Cyclosporine (CsA) Versus Tacrolimus (Tacro) After Campath Induction in Kidney Transplantation
Clinical trial comparing cyclosporine versus tacrolimus after Campath induction in kidney transplantation is completed. Results were posted …
-
CLINICAL_TRIALS research · 2016-07-14Clinical Trial Update: Regenerative Cellular Therapies, Physiology, Pathology and Developmental Biology
This update reports on a regenerative cellular therapies trial focused on graft rejection and transplantation, with diabetes mellitus also l…
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Kidney Transplant Recipients [Phase 3]
Phase 3 randomized trial comparing Tacrolimus (Prograf) with Prograf-XL in de novo kidney transplant recipients; study completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-07-09Clinical Trial Update: A Pilot Study to Evaluate the Use of C1 Esterase Inhibitor (Human) in Patients With Acute Antibody-Mediated Rejection [Phase 2]
Phase 2 trial evaluating human C1 esterase inhibitor for acute antibody-mediated rejection in transplant patients has completed with posted …
-
CLINICAL_TRIALS trial_result · 2014-01-13Clinical Trial Update: Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted Kidney [Phase 2]
This Phase 2 trial compared belatacept with cyclosporine in kidney transplant recipients to assess safety and efficacy. Results were posted …
-
CLINICAL_TRIALS trial_result · 2011-08-25Clinical Trial Update: Azithromycin in Bronchiolitis Obliterans Syndrome [Phase 4]
Phase 4 trial update evaluating azithromycin in Bronchiolitis Obliterans Syndrome, including graft rejection and related respiratory conditi…
-
CLINICAL_TRIALS trial_result · 2011-06-16Clinical Trial Update: A Study on a New Staining Method (C4d Staining) of Transplanted Kidney Biopsies
This completed trial evaluated a new C4d staining method on kidney transplant biopsy samples to assess its utility in diagnosing graft rejec…
-
CLINICAL_TRIALS trial_result · 2011-05-23Clinical Trial Update: Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant Recipients [Phase 4]
Phase 4 study assessing safety and efficacy of converting from a calcineurin inhibitor to sirolimus in renally impaired heart transplant rec…
-
CLINICAL_TRIALS trial_result · 2011-05-10Clinical Trial Update: Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients [Phase 3]
Phase 3 trial comparing Everolimus with reduced cyclosporine versus mycophenolic acid with cyclosporine in kidney transplant recipients; the…
-
CLINICAL_TRIALS trial_result · 2011-03-08Clinical Trial Update: Study Comparing Conversion From Calcineurin Inhibitors to Rapamune Versus Standard Therapy in Established Renal Allograft Recipients [Phase 3]
A Phase 3 trial comparing conversion from calcineurin inhibitors to Rapamune (sirolimus) versus standard therapy in established renal allogr…
-
CLINICAL_TRIALS trial_result · 2010-07-12Clinical Trial Update: Safety/Efficacy of Everolimus and Neoral® in Adult Cardiac Transplant Patients With Established Allograft Vasculopathy [Phase 3]
A completed Phase 3 trial evaluating the safety and efficacy of everolimus in combination with cyclosporine (Neoral) in adult heart transpla…
-
CLINICAL_TRIALS trial_result · 2009-03-09Clinical Trial Update: Cardiac Allograft Rejection Gene Expression Observational (CARGO) II STUDY
The Cardiac Allograft Rejection Gene Expression Observational (CARGO) II study has completed, evaluating rejection-associated gene expressio…
-
EMA withdrawal · 2009-02-13EMA Withdrawn: Zenapax (daclizumab) — Roche Registration Ltd.
EMA has withdrawn Zenapax (daclizumab) from the market in January 2007.
-
CLINICAL_TRIALS trial_result · 2008-12-18Clinical Trial Update: Lung Allograft Rejection Gene Expression Observational (LARGO) Study
The LARGO study, an observational trial evaluating gene-expression markers for lung allograft rejection, has been terminated.